Surrozen, Inc. logo

Surrozen, Inc.

NASDAQ:SRZN

Overview | Financials
Company Name Surrozen, Inc.
Symbol SRZN
Currency USD
Price 8.01
Market Cap 25,678,859
Dividend Yield 0%
52-week-range 4.5 - 16.19
Industry Biotechnology
Sector Healthcare
CEO Mr. Craig C. Parker M.B.A.
Website https://www.surrozen.com

An error occurred while fetching data.

About Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its

Related Stocks

Celcuity Inc. logo

Celcuity Inc.

CELC

15.01 USD

MyMD Pharmaceuticals, Inc. logo

MyMD Pharmaceuticals, Inc.

MYMD

1.81 USD

Equillium, Inc. logo

Equillium, Inc.

EQ

0.85 USD

Fortress Biotech, Inc. logo

Fortress Biotech, Inc.

FBIO

1.92 USD

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.

DARE

3.23 USD

Financials

Numbers are in millions USD

Numbers are in millions USD